Exendin-4 promotes beta cell proliferation via PI3k/Akt signalling pathway

Cellular Physiology and Biochemistry

Volumn 35, Issue 6, 2015, Pages 2223-2232

  Wang, Chaoxun ^a   Chen, Xiaopan ^b   Ding, Xiaoying ^c   He, Yanju ^a   Gu, Chengying ^a   Zhou, Ligang ^a  

^a FUDAN UNIVERSITY PUDONG MEDICAL CENTER   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Beta cell proliferation; Diabetes; Exendin 4; Incretin; PI3k Akt

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; EXENDIN 4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; PEPTIDE; VENOM;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BRDU ASSAY; CELL COUNT; CELL MASS; CELL PROLIFERATION; CELLULAR PARAMETERS; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SHAM PROCEDURE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; FEMALE; INSULIN-SECRETING CELLS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; PEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; VENOMS;

EID: 84928128726     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374027     Document Type: Article

References (34)

1. Weir GC, Bonner-Weir S: Islets of langerhans: The puzzle of intraislet interactions and their relevance to diabetes. J Clin Invest 1990;85:983-987.
2. Murtaugh LC, Melton DA: Genes, signals, and lineages in pancreas development. Annu Rev Cell Dev Biol 2003;19:71-89.
3. Zaret KS, Grompe M: Generation and regeneration of cells of the liver and pancreas. Science 2008;322:1490-1494.
4. Edlund H: Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nat Rev Genet 2002;3:524-532.
5. Dor Y, Brown J, Martinez OI, Melton DA: Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004;429:41-46.
6. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA: Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 2007;12:817-826.
7. Meier JJ, Butler AE, Saisho Y, Monchamp T, Galasso R, Bhushan A, Rizza RA, Butler PC: Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008;57:1584-1594.
8. Georgia S, Bhushan A: Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 2004;114:963-968.
9. Xiao X, Chen Z, Shiota C, Prasadan K, Guo P, El-Gohary Y, Paredes J, Welsh C, Wiersch J, Gittes GK: No evidence for beta cell neogenesis in murine adult pancreas. J Clin Invest 2013;123:2207-2217.
10. Johansson M, Mattsson G, Andersson A, Jansson L, Carlsson PO: Islet endothelial cells and pancreatic betacell proliferation: Studies in vitro and during pregnancy in adult rats. Endocrinology 2006;147:2315-2324.
11. Butler AE, Cao-Minh L, Galasso R, Rizza RA, Corradin A, Cobelli C, Butler PC: Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010;53:2167-2176.
12. Rieck S, Kaestner KH: Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab 2010;21:151-158.
13. Schraenen A, de Faudeur G, Thorrez L, Lemaire K, Van Wichelen G, Granvik M, Van Lommel L, in't Veld P, Schuit F: Mrna expression analysis of cell cycle genes in islets of pregnant mice. Diabetologia 2010;53:2579-2588.
14. Xue Y, Liu C, Xu Y, Yuan Q, Xu K, Mao X, Chen G, Wu X, Brendel MD, Liu C: Study on pancreatic islet adaptation and gene expression during pregnancy in rats. Endocrine 2010;37:83-97.
15. Zhao X: Increase of beta cell mass by beta cell replication, but not neogenesis, in the maternal pancreas in mice. Endocr J 2014;61:623-628.
16. Drucker DJ: Incretin action in the pancreas: Potential promise, possible perils, and pathological pitfalls. Diabetes 2013;62:3316-3323.
17. Lovshin JA, Drucker DJ: Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009;5:262-269.
18. Amori RE, Lau J, Pittas AG: Efficacy and safety of incretin therapy in type 2 diabetes: Systematic review and meta-analysis. JAMA 2007;298:194-206.
19. Drucker DJ, Nauck MA: The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368:1696-1705.
20. Heller C, Kuhn MC, Mulders-Opgenoorth B, Schott M, Willenberg HS, Scherbaum WA, Schinner S: Exendin-4 upregulates the expression of wnt-4, a novel regulator of pancreatic beta-cell proliferation. Am J Physiol Endocrinol Metab 2011;301:E864-872.
21. Perez-Arana G, Blandino-Rosano M, Prada-Oliveira A, Aguilar-Diosdado M, Segundo C: Decrease in {beta}-cell proliferation precedes apoptosis during diabetes development in bio-breeding/worcester rat: Beneficial role of exendin-4. Endocrinology 2010;151:2538-2546.
22. Arakawa M, Ebato C, Mita T, Hirose T, Kawamori R, Fujitani Y, Watada H: Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents. Biochem Biophys Res Commun 2009;390:809-814.
23. Aviv V, Meivar-Levy I, Rachmut IH, Rubinek T, Mor E, Ferber S: Exendin-4 promotes liver cell proliferation and enhances the pdx-1-induced liver to pancreas transdifferentiation process. J Biol Chem 2009;284:33509-33520.
24. Song WJ, Schreiber WE, Zhong E, Liu FF, Kornfeld BD, Wondisford FE, Hussain MA: Exendin-4 stimulation of cyclin a2 in beta-cell proliferation. Diabetes 2008;57:2371-2381.
25. Xie J, El Sayed NM, Qi C, Zhao X, Moore CE, Herbert TP: Exendin-4 stimulates islet cell replication via the igf1 receptor activation of mtorc1/s6k1. J Mol Endocrinol 2014;53:105-115.
26. Tian L, Gao J, Weng G, Yi H, Tian B, O'Brien TD, Guo Z: Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts. Transpl Int 2011;24:856-864.
27. Xu G, Stoffers DA, Habener JF, Bonner-Weir S: Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999;48:2270-2276.
28. Rankin MM, Kushner JA: Adaptive beta-cell proliferation is severely restricted with advanced age. Diabetes 2009;58:1365-1372.
29. Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA: Very slow turnover of beta-cells in aged adult mice. Diabetes 2005;54:2557-2567.
30. Xiao X, Wiersch J, El-Gohary Y, Guo P, Prasadan K, Paredes J, Welsh C, Shiota C, Gittes GK: Tgfbeta receptor signaling is essential for inflammation-induced but not beta-cell workload-induced beta-cell proliferation. Diabetes 2013;62:1217-1226.
31. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, Song Z, El-Gohary Y, Prasadan K, Shiota C, Gittes GK: M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci U S A 2014;111:E1211-1220.
32. Yang W, Zhang Y, Li Y, Wu Z, Zhu D: Myostatin induces cyclin d1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/akt/gsk-3 beta pathway and is antagonized by insulin-like growth factor 1. J Biol Chem 2007;282:3799-3808.
33. Shelton JG, Blalock WL, White ER, Steelman LS, McCubrey JA: Ability of the activated pi3k/akt oncoproteins to synergize with mek1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells. Cell Cycle 2004;3:503-512.
34. Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM, Medema RH: Cell cycle inhibition by foxo forkhead transcription factors involves downregulation of cyclin d. Mol Cell Biol 2002;22:7842-7852.